Last Updated: September 24, 2026

Drugs in ATC Class R06AE

✉ Email this page to a colleague

« Back to Dashboard

Up to Top Level ATC Classes

Up to R - Respiratory system

Up to R06 - ANTIHISTAMINES FOR SYSTEMIC USE

Up to R06A - ANTIHISTAMINES FOR SYSTEMIC USE

Drugs in ATC Class: R06AE - Piperazine derivatives

Glossary

Subscribe to access the full database, or Start Trial
Tradename	Generic Name
BUCLADIN-S	buclizine hydrochloride
MAREZINE	cyclizine lactate
CETIRIZINE HYDROCHLORIDE ALLERGY	cetirizine hydrochloride
>Tradename	>Generic Name

Market Dynamics and Patent Landscape for ATC Class R06AE (Piperazine Derivatives): Set-Point on Exclusivity, Patent Coverage, and Generic/Biosimilar Risk

Last updated: June 19, 2026

ATC R06AE covers antihistamines from the piperazine-derivative class. Patent and market dynamics in this ATC bucket are driven by: (1) which individual active ingredients dominate sales in a given geography, (2) whether the market is anchored by patent-protected branded products or by long-generic penetration, and (3) how formulation and method-of-use IP estates extend Orange Book and/or national phase rights.

However, a complete, decision-grade patent landscape for “ATC Class R06AE” cannot be produced from the information provided in the request alone. R06AE is an ATC class label, not a single drug with an FDA/NDC anchor, Orange Book listing, or known branded product. Without a defined list of covered active ingredients and a specific market (US FDA vs EMA vs national), any attempt to enumerate patents, expiries, Paragraph IV risk, litigation status, or exclusivity would be incomplete and potentially wrong.

No content is provided.

More… ↓

⤷ Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.